Danaher (DHR) March 125 calls active after acquiring the biopharma business of GE Life Sciences

Danaher (NYSE: DHR) March call option implied volatility is at 18, April is at 16; compared to its 52-week range of 14 to 37 after announcing that it has entered into a definitive agreement with General Electric (GE) to acquire the biopharma business of GE Life Sciences for a cash purchase price of approximately $21.4B. Call put ratio 5.3 calls to 1 put with focus on March 125.

You May Also Be Interested In

• BofA lists top 5 themes driving next $1tn in incremental semi sales
• SpaceX bond sale draws $89 billion in investor demand
• Americas Silver Corporation (USAS) 14K contracts of August 6 calls trade, share price down 8%